Status:
COMPLETED
Using Artificial Intelligence (AI)-Assisted Pulse Diagnosis Analysis on Precision Critical Medicine.
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
ICU Patients
Shock
Eligibility:
All Genders
20-80 years
Brief Summary
Precision/personalized medicine becomes an important part of modern medical system in the recent years. In the past, the treatments for patients have been decided by doctors according patients' sympto...
Eligibility Criteria
Inclusion
- The patient in ICU is willing to participate in the research project or patient's family member is willing patient to participate in the research project.
- Acute circulatory failure
Exclusion
- 1\. The patient do not want to participate in the research project or patient's family member do not want the patient to participate in the research project.
- 2\. Pregnant woman.
- 3\. Goals of treatment is palliative care.
- 4\. Patient is heritable immunodeficiency or acquired immunodeficiency.
- 5\. Known existing cardiac arrhythmia, valvular heart disease, right ventricular dysfunction, intra-cardiac shunt, air leaking from chest drains, abdominal compartment syndrome.
Key Trial Info
Start Date :
November 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 6 2022
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04675424
Start Date
November 15 2020
End Date
October 6 2022
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital, Linkou branch
Taoyuan District, Taiwan, 33378